IN BRIEF: Arix Bioscience Investee Plans LB-001 Trial After US FDA Ok Read More
IN BRIEF: Arix Bioscience Notes Positive Data From Amplyx's Study Read More
IN BRIEF: Arix's Atox To Submit Reltecimod Drug Application To US FDA Read More
IN BRIEF: Arix's VelosBio Pockets USD137 Million In Fundraise Read More
UK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks Read More
UK Shareholder Meetings Calendar - Next 7 Days Read More
Arix Bioscience Notes First Patient Dosed In Harpoon's HPN217 Trial Read More
Syncona, Arix Note US FDA Acceptance Of Autolus Drug Application Read More
UK EXECUTIVE CHANGE SUMMARY: Two Co-Founders Leave Arix Bioscience Read More
Arix Biosciences Invests Further Into Imara Following US IPO Pricing Read More
Arix Bioscience Net Asset Value Declines In 2019 Amid Challenges Read More
Arix Bioscience Investee US IPO Price Set At USD16 To USD18 Per Share Read More
UK Earnings, Trading Statements Calendar - Next 7 Days Read More
Arix Bioscience Portfolio Company Imara Gears Up For US Float Read More
Syncona, Arix Note New Data From Autolus Trial Of AUTO3 Cell Therapy Read More
Arix Bioscience Investee Quench Bio Completes Series A Financing Read More
Syncona, Arix Note Pricing Of Public Offering By Autolus Therapeutics Read More
Arix Bioscience To Invest USD2 Million In Iterum Private Placing Read More
Arix Bioscience Names Former Smith & Nephew Science Head As Non-Exec Read More
Arix Bioscience Investee Iterum Posts Positive Sulopenem Trial Results Read More
